SPY305.55+1.23 0.40%
DIA255.27+0.98 0.39%
IXIC9,552.05+62.18 0.66%

HC Wainwright & Co. Reiterates Buy on Bio-Path Holdings, Lowers Price Target to $18

HC Wainwright & Co. reiterates Bio-Path Holdings (NASDAQ:BPTH) with a Buy and lowers the price target from $25 to $18.

Benzinga · 05/18/2020 11:28

HC Wainwright & Co. reiterates Bio-Path Holdings (NASDAQ:BPTH) with a Buy and lowers the price target from $25 to $18.